The Radboud University Medical Center, is the teaching hospital affiliated with the Radboud University Nijmegen, in the city of Nijmegen in the eastern-central part of the Netherlands. The Radboud University Medical Center was founded in 1956.

There are 1,065 beds in Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology.

During the past decade, Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology" are "Ischemia-Reperfusion Injury" (3 trials), "Caffeine" (1 trials) and "Ischemic Preconditioning" (1 trials). Many other conditions were trialed in "Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology" in a lesser frequency.

Most popular intervention types in "Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology" are "Drug" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Technetium-TC99m-labeled Annexin A5" (2 trials), "caffeine" (2 trials), "acetylcholine" (1 trials), "adenosine" (1 trials) and "forearm ischemic exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Radboud University Nijmegen Medical Centre / Department of Pharmacology and Toxicology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".